Angela Murphy, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 5 S Washington Ave, Jermyn, PA 18433 Phone: 570-230-0019 |
Kayla Gatto, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 5 S Washington Ave, Jermyn, PA 18433 Phone: 570-230-0019 |
Maggie O'hara Dempsey, CRNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 5 S Washington Ave, Jermyn, PA 18433 Phone: 570-230-0019 |
Colleen Marie Dougherty, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 5 S Washington Ave, Jermyn, PA 18433 Phone: 570-230-0019 Fax: 270-230-0013 |
Amanda Rose Turoni, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 5 S Washington Ave, Jermyn, PA 18433 Phone: 570-230-0019 |
Joshua Braddell, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 5 S Washington Ave, Jermyn, PA 18433 Phone: 570-230-0019 |
Nicole Marie Martin, CRNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 5 S Washington Ave, Jermyn, PA 18433 Phone: 570-417-8407 |
News Archive
Human adenovirus (HAdV) infections in Singapore and Malaysia have caused severe respiratory disease among children and adults in recent years, but scientists still don't know whether these outbreaks are due to new or re-emerging virus strains.
Researchers are increasingly aware that fat in some parts of the body is more harmful than fat in other places. To help determine how obesity works, scientists turn to animal models and now, they are able to visualize how much fat their lab rats are carrying and where they are storing it.
Scientists at the University of California, Santa Barbara have made an important discovery that will increase the understanding of multiple sclerosis, a debilitating disease of the central nervous system in which the myelin sheath, an insulating membrane surrounding the nerve cells in the brain and spinal cord, start to unravel for reasons as yet unknown.
ZymoGenetics, Inc. today announced that it has priced an underwritten public offering of 14,000,000 shares of its common stock at a price of $6.00 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $79,000,000.
› Verified 6 days ago